Artificial Intelligence is often hailed as the future of healthcare, with promises of revolutionizing drug discovery, personalized treatments, and operational efficiency. However, in the emerging field of cell and gene therapy, the application of AI presents a number of limitations and challenges that often go overlooked. This session will explore the real-world barriers to AI’s success in this critical area, offering a skeptical perspective on its true potential. In this session, you will learn more about:

• The limitations of AI in understanding the complexities of human biology and its ability to handle the unique challenges in cell and gene therapy.
• How data quality, scarcity, and integration issues impact the effectiveness of AI-driven therapies in CGT.
• The importance of human expertise in guiding AI technology and ensuring its responsible and effective use in clinical settings.